Caffeine’s inability to ameliorate IL-6 and hepatocyte-specific STAT3 gene deletion NAFLD in mice suggests that the IL6/STAT3 pathway is required for caffeine’s hepatoprotective action in NAFLD [45]. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.